SYRE Competitors & Alternatives
Compare Spyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
SYRE
Main Stock$106.49
Tradestie Score
41
Market Cap
$994.20M
Analyst Upside
+17.1%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BMRN
BioMarin Pharmaceuticals Inc
|
$66.70
|
$10.53B | 188.0 | 42 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$59.74
|
$10.49B | - | 40 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$81.50
|
$10.22B | - | 52 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$516.74
|
$10.01B | - | 51 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.32
|
$9.33B | 61.9 | 51 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$122.25
|
$8.88B | 263.2 | 40 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$108.17
|
$8.77B | 31.6 | 35 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$209.46
|
$8.57B | - | 47 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$26.27
|
$8.53B | 2.4 | 37 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$254.28
|
$8.30B | 17.3 | 55 | Compare |
More SYRE Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry